Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$8.95M Buy
112,414
+752
+0.7% +$60.6K 0.34% 76
2023
Q4
$10M Buy
111,662
+22,258
+25% +$1.92M 0.42% 68
2023
Q3
$8.81M Buy
89,404
+1,214
+1% +$125K 0.41% 69
2023
Q2
$9M Buy
88,190
+35,140
+66% +$3.47M 0.41% 63
2023
Q1
$5.95M Buy
53,050
+32,727
+161% +$3.61M 0.28% 74
2022
Q4
$1.89M Sell
20,323
-1,587
-7% -$151K 0.08% 115
2022
Q3
$1.71M Buy
21,910
+357
+2% +$34.2K 0.08% 116
2022
Q2
$1.92M Buy
21,553
+20,953
+3,492% +$2.14M 0.08% 120
2022
Q1
$72K Hold
600
﹤0.01% 477
2021
Q4
$99K Buy
+600
New +$100K ﹤0.01% 422

Other funds holding APTV

Cambridge Trust's APTV Position: Q1 2024 in Review

Cambridge Trust increased its Aptiv (APTV) stake by 0.67% in Q1 2024, buying an estimated $60.6K and bringing the position to 112,414 shares worth $8.95M. The position accounts for 0.34% of the portfolio, ranked #76.

Cambridge Trust first reported a position in APTV in Q4 2021 and has held it in 10 quarters since. The position peaked at $10M in Q4 2023. 744 funds tracked by Wall St. Rank hold APTV as of Q1 2024.

  • Cambridge Trust held 112,414 shares of Aptiv worth $8.95M as of Q1 2024.
  • Cambridge Trust bought 752 Aptiv shares in Q1 2024, an estimated $60.6K.
  • Aptiv made up 0.34% of Cambridge Trust's portfolio in Q1 2024, its #76 holding.
  • Cambridge Trust first reported a position in Aptiv in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's Aptiv position peaked at $10M in Q4 2023.
  • 744 funds tracked by Wall St. Rank held Aptiv as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.